Pontchartrain Cancer Center

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Colorectal cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Melanoma1 trial
• Myeloproliferative neoplasms1 trial
• Pancreatic cancer1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Pfizer1 trial
• Protagonist Therapeutics, Inc.1 trial
• Shanghai Henlius Biotech1 trial
• Tempus AI1 trial

Running trials

• Recruiting

  Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT07222566· Phase 3· Pfizer· Source

• Active, not recruiting

  To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

  NCT05468489· Phase 2· Shanghai Henlius Biotech· Source

• Active, not recruiting

  A Study of Rusfertide in Adults With Polycythemia Vera (PV)

  NCT05210790· Phase 3· Protagonist Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Terminated

  Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

  NCT05169437· Phase 2· Tempus AI· Source